Abstract: A pharmaceutical composition of drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation of drospirenone and ethynylestradiol in order to improve its dissolution profile. The formulation can be used to produce an anovulatory effect when administered correctly in humans.
Type:
Application
Filed:
August 2, 2005
Publication date:
September 10, 2009
Applicant:
Laboratories Liconse, S.A.
Inventors:
Carlos Ariel Sandrone, Jose Mario Sakson, Maria del Carmen Cajarville Basaistegui, Jose Daniel Larrosa Pomi